Cervical Mesonephric Hyperplasia Lacks KRAS/NRAS mutations

Abstract

Mesonephric carcinoma, a rare malignant tumor thought to be derived from mesonephric remnants and/or hyperplasia, has recently been characterized by recurrent KRAS/NRAS mutations (1). The molecular features of mesonephric hyperplasia and whether it truly represents a precursor lesion to mesonephric carcinoma are unknown.

This article is protected by copyright. All rights reserved.

http://ift.tt/2uckaOB